Sign inGet started

Sachs Jessica

Insider CIK 1782545 · UMRX Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
COGT Cogent Biosciences, Inc. S Sale2025-12-262025-12-3082,642$38.70 $3.20M133,938SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2025-12-172025-12-1965,000— $065,000SEC↗
COGT Cogent Biosciences, Inc. A Award2025-12-172025-12-1950,000— $051,296SEC↗
COGT Cogent Biosciences, Inc. A Award2025-12-172025-12-19320,000— $0371,296SEC↗
COGT Cogent Biosciences, Inc. F Tax w/h2025-12-172025-12-19154,716$39.45 $6.10M216,580SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2025-01-232025-01-27270,000— $0270,000SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2024-01-232024-01-25300,000— $0300,000SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2023-02-132023-02-15160,000— $0160,000SEC↗
COGT Cogent Biosciences, Inc. A Award2022-06-302022-07-01622$7.40 $4.6K622SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2022-01-252022-01-27250,000$4.94 $1.24M250,000SEC↗
COGT Cogent Biosciences, Inc. A Award2021-12-312022-01-04674$6.82 $4.6K674SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2021-02-102021-02-12126,500— $0126,500SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2021-02-012021-02-02400,000— $0400,000SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2020-02-112020-02-13133,200— $0133,200SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2019-07-192019-07-22123,800— $0123,800SEC↗